Haley du Bois

Haley du Bois

Auto-generated profile, based on publicly available information

Haley du Bois

Department of Tumor Microenvironment and Metastasis, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Nature
Verified
Journal Article
Closed access
PDF file
AYAndrew C. Yang
Andrew C. Yang
MSMarc Y. Stevens
Marc Y. Stevens
MCMichelle B. Chen
Michelle B. Chen
DLDavis P. Lee
Davis P. Lee
DSDaniel Stähli
Daniel Stähli
TWTony Wyss-Coray
Tony Wyss-Coray

3 September 2021 in Science Immunology
Verified
Journal Article
Closed access
HBHaley du Bois
Haley du Bois
THTaylor A. Heim
Taylor A. Heim
ALAmanda W. Lund
Amanda W. Lund
Tumors remodel their draining lymph nodes to simultaneously affect both metastatic potential and systemic immune surveillance.

30 March 2022 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
MCMadeline J. Churchill
Madeline J. Churchill
HBHaley du Bois
Haley du Bois
THTaylor A. Heim
Taylor A. Heim
TMTenny Mudianto
Tenny Mudianto
MSMaria M. Steele
Maria M. Steele
ALAmanda W. Lund
Amanda W. Lund
Lymphatic vessels are often considered passive conduits that flush antigenic material, pathogens, and cells to draining lymph nodes. Recent evidence, however, suggests that lymphatic vessels actively regulate diverse processes from antigen transport to leukocyte trafficking and dietary lipid absorption. Here we tested the hypothesis that infection-induced changes in lymphatic transport actively contribute to innate host defense. We demonstrate that cutaneous vaccinia virus infection by scarification activates dermal lymphatic capillary junction tightening (zippering) and lymph node lymphangiogenesis, which are associated with reduced fluid transport and cutaneous viral sequestration. Lymphatic-specific deletion of VEGFR2 prevented infection-induced lymphatic capillary zippering, increased fluid flux out of tissue, and allowed lymphatic dissemination of virus. Further, a reduction in dendritic cell migration to lymph nodes in the absence of lymphatic VEGFR2 associated with reduced antiviral CD8+ T cell expansion. These data indicate that VEGFR2-driven lymphatic remodeling is a context-dependent, active mechanism of innate host defense that limits viral dissemination and facilitates protective, antiviral CD8+ T cell responses.

18 May 2018 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
AYAndrew C. Yang
Andrew C. Yang
HBHaley du Bois
Haley du Bois
NONiclas Olsson
Niclas Olsson
DGDavid Gate
David Gate
BLBenoit Lehallier
Benoit Lehallier
TWTony Wyss-Coray
Tony Wyss-Coray

15 March 2017 in Biotechnology Journal
Verified
Journal Article
Closed access
PDF file
AFAlfonso P. Farruggio
Alfonso P. Farruggio
MBMital S. Bhakta
Mital S. Bhakta
HBHaley du Bois
Haley du Bois
JMJulia Ma
Julia Ma
MCMichele P. Calos
Michele P. Calos

1 December 2017 in Molecular Therapy - Methods & Clinical Development
Verified
Journal Article
Open access
JMJulia Ma
Julia Ma
CPChristophe Pichavant
Christophe Pichavant
HBHaley du Bois
Haley du Bois
MBMital Bhakta
Mital Bhakta
MCMichele P. Calos
Michele P. Calos
Mutations in the gene for dysferlin cause a degenerative disorder of skeletal muscle known as limb girdle muscular dystrophy 2B. To achieve gene delivery of plasmids encoding dysferlin to hind limb muscles of dysferlin knockout mice, we used a vascular injection method that perfused naked plasmid DNA into all major muscle groups of the hind limb. We monitored delivery by luciferase live imaging and western blot, confirming strong dysferlin expression that persisted over the 3-month time course of the experiment. Co-delivery of the follistatin gene, which may promote muscle growth, was monitored by ELISA. Immunohistochemistry documented the presence of dysferlin in muscle fibers in treated limbs, and PCR confirmed the presence of plasmid DNA. Because dysferlin is involved in repair of the sarcolemmal membrane, dysferlin loss leads to fragile sarcolemmal membranes that can be detected by permeability to Evan's blue dye. We showed that after gene therapy with a plasmid encoding both dysferlin and follistatin, statistically significant reduction in Evan's blue dye permeability was present in hamstring muscles. These results suggest that vascular delivery of plasmids carrying these therapeutic genes may lead to simple and effective approaches for improving the clinical condition of limb girdle muscular dystrophy 2B.